Search

Your search keyword '"Medicine, Experimental -- Political aspects"' showing total 1,067 results

Search Constraints

Start Over You searched for: Descriptor "Medicine, Experimental -- Political aspects" Remove constraint Descriptor: "Medicine, Experimental -- Political aspects"
1,067 results on '"Medicine, Experimental -- Political aspects"'

Search Results

1. Studies from Korea University in the Area of Colitis Described [in Vitro and in Vivo Effects of Pectin-type Polysaccharides Isolated From Crabapples (malus Prunifolia) On Inflammatory Colitis Model

2. Critical gaps in clinical trials raised in Parliament amid concerns over ethical standards and quality control

3. Long a ‘Crown Jewel’ of Government, N.I.H. Is Now a Target

4. WEXTON, WARNER, AND KAINE APPLAUD PASSAGE OF THEIR BIPARTISAN GABRIELLA MILLER KIDS FIRST RESEARCH ACT

5. VIDEO: WEXTON, KAINE AND WARNER APPLAUD SENATE PASSAGE OF GABRIELLA MILLER KIDS FIRST RESEARCH ACT 2.0

6. House Covid-19 panel releases final report criticizing public health response to the pandemic

7. Medicine professor Jay Bhattacharya, COVID lockdown critic, selected to lead NIH Login or create an account

8. Vaccine uptake influenced by politics, socioeconomics

9. VACCINE UPTAKE INFLUENCED BY POLITICS, SOCIOECONOMICS

10. Edgewise Therapeutics to Present on Sevasemten (EDG-5506) for Becker Muscular Dystrophy (Becker) at the 29th International Annual Congress of the World Muscle Society

12. New NIH director fields pet project asks before spending panel

13. Studies from University of Minho Add New Findings in the Area of COVID-19 (Politics and confidence toward the COVID-19 vaccination: A Brazilian cross-sectional study)

14. Mitsubishi Tanabe Pharma America to Highlight Data on Investigational ND0612 at the 2024 International Congress of Parkinson's Disease and Movement Disorders

15. Mitsubishi Tanabe Pharma America to Highlight Data on Investigational ND0612 at the 2024 International Congress of Parkinson's Disease and Movement Disorders

16. CHAIR RODGERS APPLAUDS SENATE PASSAGE OF LEGISLATION TO FURTHER RESEARCH FOR PATIENTS WITH CONGENITAL HEART DISEASE

17. U.S. HOUSE MEMBERS INTRODUCE RESOLUTION DESIGNATING SEPT. 16-20 AS MEDICAL RESEARCH WEEK

18. HOUSE PASSES MCMORRIS RODGERS' BIPARTISAN LEGISLATION TO PRESERVE FUNDING FOR DOWN SYNDROME RESEARCH

19. BostonGene Announces Acceptance of Three Abstracts for Presentation at ESMO Congress 2024

20. CAPITO, REED INTRODUCE BIPARTISAN PLAN TO ACCELERATE PEDIATRIC RARE DISEASE RESEARCH AND TREATMENT ADVANCES

21. KAINE, DUCKWORTH, MARKEY PRESS SOCIAL SECURITY ADMINISTRATION TO HELP THOSE WITH LONG COVID OVERCOME BARRIERS TO DISABILITY BENEFITS

22. DURBIN INTRODUCES LEGISLATION TO ENSURE STABLE, ROBUST FUNDING FOR BIOMEDICAL RESEARCH

23. DURBIN, DUCKWORTH ANNOUNCE MORE THAN $2.27 MILLION IN MEDICAL RESEARCH GRANTS FOR ILLINOIS

24. Mitsubishi Tanabe Pharma America to Present Latest Parkinson's Disease Research at the 10th Congress of the European Academy of Neurology

26. Long COVID advocates ask Congress to improve federal response

27. Datavant to Showcase AI Innovations in Clinical Trials at AI Demonstration Day on Capitol Hill

28. Mitsubishi Tanabe Pharma America to Present Latest Parkinson's Disease Research at the 10th Congress of the European Academy of Neurology

29. DURBIN, DUCKWORTH ANNOUNCE MORE THAN $4.4 MILLION IN MEDICAL RESEARCH GRANTS FOR ILLINOIS

30. DUCKWORTH, DURBIN ANNOUNCE MORE THAN $4.4 MILLION IN MEDICAL RESEARCH GRANTS FOR ILLINOIS

31. Johnson & Johnson spotlights nipocalimab at FMF Congress 2024 - the first and only FcRn blocker to be studied in maternal fetal diseases

32. REPS. LEE, DAVIS, BURGESS INTRODUCE BICAMERAL, BIPARTISAN WORLD SICKLE CELL AWARENESS DAY RESOLUTION

33. GOVERNOR RON DESANTIS HIGHLIGHTS SIGNIFICANT STATE INVESTMENTS AND SIGNS LEGISLATION RELATED TO HEALTH CARE AND CANCER TREATMENT

34. DURBIN, DUCKWORTH ANNOUNCE MORE THAN $15 MILLION IN HEALTH CARE RELATED GRANTS FOR ILLINOIS

35. Sumitomo Pharma Presents New Clinical Data on DSP-5336 at the European Hematology Association 2024 Congress

36. Samsung Bioepis Presents Post-hoc Analysis of Phase 3 Study for EPYSQLI(TM) (SB12; Eculizumab Biosimilar), at the European Hematology Association (EHA) Congress 2024

37. Kidney Care Partners Applauds Senate Reintroduction of The Chronic Kidney Disease Improvement in Research and Treatment Act

38. Sequana Medical announces data on alfapump(R) safety and quality of life to be presented at EASL Congress 2024

39. Sequana Medical announces data on alfapump(R) safety and quality of life to be presented at EASL Congress 2024

40. AI Integration and Real-World Utility of CareDx Portfolio Highlighted in New Data at the 2024 American Transplant Congress

41. DURBIN, DUCKWORTH ANNOUNCE MORE THAN $8.6 MILLION FOR MEDICAL RESEARCH AND HEALTH CENTER PROGRAMS IN ILLINOIS

42. Commission Implementing Regulation (EU) 2024|1381 of 23 May 2024 laying down, pursuant to Regulation (EU) 2021|2282 on health technology assessment, procedural rules for the interaction during, exchange of information on, and participation in, the preparation and update of joint clinical assessments of medicinal products for human use at Union level, as well as templates for those joint clinical assessments

43. Seal Rock Therapeutics to Present Preclinical Efficacy Findings for SRT-015 in Cholestatic Liver Diseases at the European Association for Study of the Liver (EASL) Congress 2024

44. 61st ERA Congress: Semaglutide significantly reduces risk of major kidney disease events, cardiovascular outcomes and mortality in patients with type 2 diabetes and chronic kidney disease, groundbreaking study reveals

45. 61st ERA Congress: Semaglutide significantly reduces risk of major kidney disease events, cardiovascular outcomes and mortality in patients with type 2 diabetes and chronic kidney disease, groundbreaking study reveals

46. Fresenius Medical Care showcases leadership and innovation in kidney care disease at 61st European Renal Association (ERA) Congress 2024

48. Jumo Health to Lead a Roundtable Discussion on Authenticity and the Patient Voice at the Annual Health Equity in Clinical Trials Congress

49. Jumo Health to Lead a Roundtable Discussion on Authenticity and the Patient Voice at the Annual Health Equity in Clinical Trials Congress

50. The 7th Emirates Family Medicine Society Congress concluded its proceedings successfully, affirming the role of advanced technologies in the field of family medicine

Catalog

Books, media, physical & digital resources